Research location
Lahr
Germany
Advertisement
Research activity in Lahr
GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 13 trials and 13 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Lahr
13 linked trials · page 1 of 1BAROSTIM THERAPY™ In Resistant HypertensionNCT02880631 · 2016-12-13 · 1 site observation
RECRUITING
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection FractionNCT02880618 · 2016-12-13 · 1 site observation
RECRUITING
Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)NCT03521934 · 2018-06-15 · 1 site observation
TERMINATED
Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)NCT03345810 · 2017-12-14 · 1 site observation
COMPLETED
Incidence and Resolution of Eribulin-Induced Peripheral NeuropathyNCT03027245 · 2016-10-13 · 1 site observation
COMPLETED
A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast CancerNCT02216786 · 2014-01-16 · 1 site observation
COMPLETED
Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe Chronic Obstructive Pulmonary Disease (COPD) (DACOTA)NCT01285167 · 2010-08-01 · 1 site observation
COMPLETED
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusNCT01042769 · 2010-02-01 · 1 site observation
COMPLETED
Coronary Artery Disease and Renal Failure RegistryNCT00679419 · 2007-12-01 · 1 site observation
UNKNOWN
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesNCT00539487 · 2007-01-01 · 1 site observation
COMPLETED
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure TrialNCT00358215 · 2006-06-01 · 1 site observation
COMPLETED
Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical PracticeNCT01077258 · 2004-04-01 · 1 site observation
COMPLETED
Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical PracticeNCT01078090 · 2003-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.